ERNA vs HON · P/E 0.0, rev $582.0K vs P/E 36, rev $9.72B
Eterna Therapeutics Inc (ERNA) versus Honeywell International Inc (HON) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Not investment advice. Open the ERNA and HON stock pages for the full models.
Not investment advice.